Virus modified tumor cell vaccines for active specific immunotherapy of micrometastases: expansion and activation of tumor-specific T cells.
Schirrmacher
V
V
Institut für Immunologie und Genetik, Deutsches Krebsforschungszentrum, Heidelberg, Federal Republic of Germany.
von Hoegen
P
P
Heicappell
R
R
D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D003131:Combined Modality Therapy; D007167:Immunotherapy; D007940:Leukemia L5178 / Q000276:immunology / Q000473:pathology / Q000601:surgery / Q000628:therapy; D008213:Lymphocyte Activation; D051379:Mice; D008811:Mice, Inbred DBA; D009362:Neoplasm Metastasis / Q000628:therapy*; D009368:Neoplasm Transplantation; D009522:Newcastle disease virus / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014407:Tumor Cells, Cultured / Q000276:immunology*
D000951:Antigens, Neoplasm